Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28041
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNguyen, Phillip C-
dc.contributor.authorManos, Kate-
dc.contributor.authorFong, Chun Y-
dc.contributor.authorSchwarer, Anthony P-
dc.contributor.authorTiong, Ing S-
dc.contributor.authorWei, Andrew H-
dc.contributor.authorKliman, David-
dc.contributor.authorCurtis, David J-
dc.date.accessioned2021-11-22T05:10:52Z-
dc.date.available2021-11-22T05:10:52Z-
dc.date.issued2021-
dc.identifier.citationInternal medicine journal 2021; 51(11): 1954-1958en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28041-
dc.description.abstractThe benefits of non-myeloablative stem cell transplant in older patients with acute myeloid leukaemia are unclear. We compare the long-term outcomes of this regimen in those aged 55-65 years in first remission with a chemotherapy only cohort that achieved durable morphologic remission. Five-year overall survival was similar (32% vs 33%, P = 0.90), as was relapse-free survival (23% vs 20%, P = 0.37). There was a trend for decreased relapse that was balanced against increased non-relapse mortality with transplantation.en
dc.language.isoeng-
dc.subjectacute myeloid leukemiaen
dc.subjectconsolidation chemotherapyen
dc.subjectelderlyen
dc.subjecthaemopoietic stem cell transplantationen
dc.subjectrelapseen
dc.subjectsurvivalen
dc.titleOutcomes of non-myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission.en
dc.typeJournal Articleen
dc.identifier.journaltitleInternal Medicine Journalen
dc.identifier.affiliationDepartment of Clinical Haematology, Alfred Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Clinical Haematology, Box Hill Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationClinical Haematologyen
dc.identifier.pubmeduri10.1111/imj.15564 Abstracten
dc.identifier.doi10.1111/imj.15564en
dc.type.contentTexten
dc.identifier.orcid0000-0002-6238-0681en
dc.identifier.orcid0000-0001-5773-103Xen
dc.identifier.orcid0000-0001-7417-4343en
dc.identifier.orcid0000-0002-7514-3298en
dc.identifier.orcid0000-0002-2020-0275en
dc.identifier.orcid0000-0001-9497-0996en
dc.identifier.pubmedid34796631-
local.name.researcherManos, Kate
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptClinical Haematology-
crisitem.author.deptClinical Haematology-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Dec 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.